- Home
- JWN vs ICUI Comparison
JWN vs ICUI Comparison
Compare JWN & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JWN
- ICUI
- Stock Information
- Founded
- JWN 1901
- ICUI 1984
- Country
- JWN United States
- ICUI United States
- Employees
- JWN N/A
- ICUI N/A
- Industry
- JWN Clothing/Shoe/Accessory Stores
- ICUI Medical/Dental Instruments
- Sector
- JWN Consumer Discretionary
- ICUI Health Care
- Exchange
- JWN Nasdaq
- ICUI Nasdaq
- Market Cap
- JWN 4.0B
- ICUI 3.8B
- IPO Year
- JWN N/A
- ICUI 1992
- Fundamental
- Price
- JWN $24.13
- ICUI $161.08
- Analyst Decision
- JWN Hold
- ICUI Buy
- Analyst Count
- JWN 14
- ICUI 4
- Target Price
- JWN $21.77
- ICUI $199.67
- AVG Volume (30 Days)
- JWN 3.6M
- ICUI 200.3K
- Earning Date
- JWN 03-04-2025
- ICUI 02-25-2025
- Dividend Yield
- JWN 3.15%
- ICUI N/A
- EPS Growth
- JWN 110.55
- ICUI N/A
- EPS
- JWN 1.55
- ICUI N/A
- Revenue
- JWN $15,112,000,000.00
- ICUI $2,340,097,000.00
- Revenue This Year
- JWN $2.42
- ICUI $4.38
- Revenue Next Year
- JWN $1.81
- ICUI $0.34
- P/E Ratio
- JWN $15.52
- ICUI N/A
- Revenue Growth
- JWN 3.56
- ICUI 4.04
- 52 Week Low
- JWN $16.79
- ICUI $86.80
- 52 Week High
- JWN $24.99
- ICUI $196.26
- Technical
- Relative Strength Index (RSI)
- JWN 56.18
- ICUI 51.79
- Support Level
- JWN $24.00
- ICUI $151.92
- Resistance Level
- JWN $24.20
- ICUI $167.49
- Average True Range (ATR)
- JWN 0.16
- ICUI 4.52
- MACD
- JWN -0.03
- ICUI 0.73
- Stochastic Oscillator
- JWN 14.61
- ICUI 61.01
About JWN Nordstrom Inc.
Nordstrom is a fashion retailer that operates about 93 department stores and 280 off-price Nordstrom Rack stores. The company also operates both full- and off-price e-commerce sites, two clearance stores, and six Local locations. Nordstrom's largest merchandise categories are women's apparel (27% of 2023 sales), shoes (26% of 2023 sales), men's apparel (15% of 2023 sales), and beauty (13% of 2023 sales). Nordstrom, which traces its history to a shoe store opened in Seattle in 1901, continues to be partially owned and managed by members of the eponymous family.
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.